Expert pediatric opinion on the Report of the Baveno IV Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension
The pediatric commentary on this published statement will be in italics (note bold italics are used for the headings in the original publication and have been changed to underlined nonitalic text for this commentary). Commentary was elicited on selected topics from Baveno IV. The remainder is reproduced with permission from the original publication ( 1). Not all topics in the Baveno IV statement were reviewed at this 1-day symposium. Those that were not reviewed have no supplementary pediatric commentary and are in a smaller font. Some sections were agreed upon in total as indicated by the use of the comment ‘‘agreed.’’
Abstract
Abstract: Portal hypertension leads to a wide variety of complications, which lead to significant morbidity and mortality and are some of the leading reasons for liver transplantation in children with chronic liver disease. Evidence-based approaches to the management of adults with portal hypertension exist and have been comprehensively reviewed in a series of international meetings, including the Baveno meetings. Similar evidence-based approaches for the management of portal hypertension in children do not exist and as such international meetings on portal hypertension have not focused on this problem in children. On October 7, 2005 at The Mount Sinai School of Medicine, a panel of pediatric experts reviewed the most recent Baveno statement and crafted a statement modified with their opinions vis a vis approaches to the management of portal hypertension in children.
